References
- Chang V. T., Hwang S. S., Feuerman M., Kasimis B. Symptom and quality of life survey of medical oncology patients at a Veterans Affairs Medical Center. A role for symptom assessment. Cancer 2000; 88: 1175–1183, [PUBMED], [INFOTRIEVE]
- De Haes J. C.J.M., van Knippenburg F. C.E., Nejit J. P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br. J. Cancer 1990; 62: 1034–1038, [PUBMED], [INFOTRIEVE]
- Portenoy R. K., Thaler H. T., Kornblith A. B., Lepore J. M., Friedlander-Klar H., Kiyasu E., Sobel K., Coyle N., Kemeney N., Norton L., Scher H. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur. J. Cancer 1994; 30A: 1326–1336, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Donnelly S., Walsh T. D. Quality of life assessment in advanced cancer. Palliat. Med. 1996; 10: 275–283, [PUBMED], [INFOTRIEVE], [CSA]
- Bruera E., Kuehn N., Miller M. J., Selmser P., Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J. Palliat. Care 1991; 7: 6–9, [PUBMED], [INFOTRIEVE]
- Murray Parkes C. Accuracy of predictions of survival in later stages of cancer. Br. Med. J. 1972; 2: 29–31
- Christakis N. A., Lamont E. B. Extent and determinants of error in doctors prognoses in terminally ill patients: prospective cohort study. Br. Med. J. 2000; 320: 469–472
- Chang V. T. The value of symptoms in prognosis of cancer patients. Topics in Palliative Care, E. Bruera, R. K. Portenoy. Oxford University Press, New York 2000; Vol. 4: 23–54
- Earlam S., Glover C., Fordy C., Burke D., Allen-Mersh T. G. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J. Clin. Oncol. 1996; 14: 171–175, [PUBMED], [INFOTRIEVE]
- Chang V. T., Polyak T., Thaler H. T., Kornblith A. B., Lepore J., Portenoy R. K. Quality of life and survival: the role of multidimensional symptom assessment. Cancer 1998; 83: 173–179, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chang V. T., Hwang S. S., Feuerman M., Kasimis B. The Memorial Symptom Assessment Scale Short Form (MSAS-SF). Validity and reliability. Cancer 2000; 89: 1162–1171, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cella D. F., Tulsky D. S., Gray G., Sarafian B., Linn E., Bonomi A., Silberman M., Yellen S. B., Winicour P., Brannon J. The functional assessment of cancer therapy scale: development and validation of the general measure. J. Clin. Oncol. 1993; 11: 570–579, [PUBMED], [INFOTRIEVE]
- Hwang S. S., Chang V. T., Kasimis B. Comparison of three fatigue measures in veterans with cancer. Cancer Investig. 2003; 21: 355–365, [CROSSREF], [CSA]
- Hwang S. S., Chang V. T., Fairclough D. L., Cogswell J., Kasimis B. Longitudinal quality of life in advanced cancer patients: pilot study results from a VA medical cancer center. J. Pain Symp. Manag. 2003; 25: 225–235, [CROSSREF], [CSA]
- Hwang S. S., Chang V. T., Fairclough D. L., Kasimis B. Development of a cancer pain prognostic scale. J. Pain Symp. Manag. 2002; 24: 366–378, [CROSSREF], [CSA]
- Heyse-Moore L. H., Ross V., Mullee M. A. How much of a problem is dyspnoea in advanced cancer?. Palliat. Med. 1991; 5: 20–26
- Escalante C. P., Martin C. G., Elting L. S., Cantor S. B., Harle T. S., Price K. J., Kish S. K., Manzullo E. F., Rubenstein E. B. Dyspnea in cancer patients. Etiology, resource utilization, and survival—implications in a managed care world. Cancer 1996; 78: 1314–1319, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Herndon J. E., II, Fleishman S., Kornblith A. B., Kosty M., Green M. R., Holland J. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?. Cancer 1999; 85: 333–340, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tannock I. F., Osoba D., Stockler M. R., Ernst D. S., Neville A. J., Moore M. J., Armitage G. R., Wilson J. J., Venner P. M., Coppin C. M., Murphy K. C. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J. Clin. Oncol. 1996; 14: 1756–1764, [PUBMED], [INFOTRIEVE]
- Dewys W. D., Begg C., Lavin P. T., Bennett J. M., Bertino J. R., Cohen M. H., Douglass H. O., Engstrom P. F., Ezdini E. Z., Horton J., Johnson G. J., Muertel C. G., Oken M. M., Perlia C., Rosenbaum C., Silverstein M. N., Skeet R. T., Sponzo R. W., Tormey D. C. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am. J. Med. 1980; 69: 491–497, [PUBMED], [INFOTRIEVE]
- Loprinzi C. L., Laurie J. A., Wieand H. S., Krook J. E., Novotny P. J., Kugler J. W., Bartel J., Law M., Bareman M., Klah N. E. Prospective evaluation of prognostic variables from patient-completed questionnaires. J. Clin. Oncol. 1995; 12: 601–607
- Hwang S. S., Chang V. T., Cogswell J., Kasimis B. Clinical relevance of fatigue levels in cancer patients at a VA medical center. Cancer 2002; 94: 2481–2489, [PUBMED], [INFOTRIEVE]
- Reuben D. B., Mor V., Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch. Intern. Med. 1988; 148: 1586–1591, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Chang V. T., Thaler H. T., Polyak T. A., Kornblith A. B., Lepore J. M., Portenoy R. K. Quality of life and survival. The role of multidimensional symptom assessment. Cancer 1998; 83: 173–179, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cassileth B. R., Walsh W. P., Lusk E. J. Psychosocial correlates of cancer survival: a subsequent report 3 to 8 years after cancer diagnosis. J. Clin. Oncol. 1988; 6: 1753–1759, [PUBMED], [INFOTRIEVE]
- Vaccarino V., Kasl S. V., Abramson J., Krumholz H. M. Depressive symptoms and risk of functional decline and death in patients with heart failure. J. Am. Coll. Cardiol. 2001; 38: 199–205, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Almagro P., Calbo E., Ochoa de Echaguen A., Barreiro B., Quintana S., Heredia J. L., Garau J. Mortality after hospitalization for COPD. Chest 2002; 121: 1441–1448, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Koenig H. G., George L. K., Larson D. B., McCullough M. E., Branch P. S., Kuchibhatla M. Depressive symptoms and nine-year survival of 1,001 male veterans hospitalized with medical illness. Am. J. Geriatr. Psychiatry 1999; 7: 124–131, [PUBMED], [INFOTRIEVE], [CSA]
- Lavretsky H., Bastani R., Gould R., Huang D., Llorente M., Maxwell A., Jarvik L., UPBEAT collaborative group. Predictors of two year mortality in a prospective “UPBEAT” study of elderly veterans with comorbid medical and psychiatric symptoms. Am. J. Geriatr. Psychiatry 2002; 10: 458–468, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ganz P. A., Lee J. J., Siau M. S. Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 1991; 67: 3131–3135, [PUBMED], [INFOTRIEVE]
- Ruckdeschel J. C., Piantadosi S., Lung Cancer Study Group. Quality of life assessment in lung surgery for bronchogenic carcinoma. Theor. Surg. 1991; 6: 201–206
- Coates A., Gebski V., Signorini D., Murray P., McNeil D., Byrne M., Forbes J. F. Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. J. Clin. Oncol. 1992; 10: 1833–1838, [PUBMED], [INFOTRIEVE]
- Coates A., Thomson D., McLeod G. R.M., Hersey P., Gill P. G., Olver I. N., et al. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur. J. Cancer 1993; 29A: 1731–1734, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Coates A., Porzsolt F., Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur. J. Cancer 1997; 33: 1025–1030, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dancey J., Zee B., Osoba D., Whitehead M., Lu F., Kaizer L., et al. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. Qual. Life Res. 1997; 6: 151–158, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Earlam S., Glover C., Fordy C., Burke D., Allen-Mersh T. G. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J. Clin. Oncol. 1996; 14: 171–175, [PUBMED], [INFOTRIEVE]
- Coates A., Gebski V. On the receiving end. VI. Which dimensions of quality of life scores carry prognostic information?. Cancer Treat. Rev. 1996; 22(Supplement A)63–67, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cleeland C., Mendoza T., Wang X. S., Chou C., Harle M. T., Morrissey M., Engstrom M. C. Assessing symptom distress in cancer patients. The MD anderson symptom inventory. Cancer 2000; 89: 1634–1646, [PUBMED], [INFOTRIEVE], [CROSSREF]
- McCorkle R., Young K. Development of a symptom distress scale. Cancer Nurs. 1978; 1: 373–378, [PUBMED], [INFOTRIEVE]
- Fisher E. S., Welch H. G. The future of the Department of Veterans Affairs health care system. JAMA 1995; 273: 651–655, [PUBMED], [INFOTRIEVE], [CROSSREF]